The GIMI is developing research projects in close partnership with a number of teams, notably within UMR INSERM 1231 and UMR INSERM 1098:
Another important advantage is the Burgundy location of the Francophone Federation of Digestive Oncology (FFCD), which manages around thirty national and international therapeutic trials, and is in charge of the development of the national ACCOMPLI program for the genomics-based treatment of colorectal cancers (6 programs, which in due course will make it possible to treat the 30% of cancers that present a genetic anomaly and are accessible to a specific treatment).